Smith Selected to Receive Lifetime Achievement Award for Migraine Research
Robert Smith, MD, professor emeritus in the department of family and community medicine, has been selected to receive the American Headache Societys (AHS) Lifetime Achievement Award, the societys highest honor, for recognition of his service to the society and to the field of headache medicine.
The award will be presented to Smith at the AHS 54th Annual Scientific Meeting in Los Angeles June 21, 2012.
Smith has played a leading role nationally and internationally in migraine headache research dating from the early 1950s. As a general practitioner in England, he won the British Medical Association Hawthorne prize for research on pain sensitivity, was a researcher with the Wellcome Foundation on migraine from 1960-63 and played an integral role in the formation of the Migraine Trust"the most prominent world organization promoting migraine research, says Smithin 1965.
Smith continued his headache research in family medicine after immigrating to the United States in 1967. He was an active member of the AHS and on its board, representing primary care practitioners, and was the founder and past director of the UC Headache Center.
He came to the University of Cincinnati in 1975 to establish the department of family medicine and was subsequently named the first Fred Lazarus Jr. Professor of Family Medicine at UC. Before coming to Cincinnati, he established the family medicine department at the University of North Carolina at Chapel Hill, one of the first family medicine departments in the U.S.
I was surprised, delighted and proud, Smith says about learning of being honored with this award. "The fact that they gave this award to a family physician was something I was very happy about as well.
Robert Smith, MD, founder of the UC Headache Center
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.